Taysha Gene Therapies Inc (TSHA)
3.09
-0.05
(-1.59%)
USD |
NASDAQ |
May 17, 16:00
3.08
-0.01
(-0.32%)
After-Hours: 17:32
Taysha Gene Therapies Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.423M |
| September 30, 2023 | -140.71M |
| June 30, 2023 | -0.50M |
| March 31, 2023 | |
| December 31, 2022 | -41.60M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | -11.64M |
| Date | Value |
|---|---|
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | |
| December 31, 2020 | 1.308M |
| September 30, 2020 | -167.16M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-167.16M
Minimum
Sep 2020
1.308M
Maximum
Dec 2020
-32.72M
Average
--
Median
Jun 2021
Stock Buybacks (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -82.10M |
| Lifecore Biomedical Inc | -- |
| Relmada Therapeutics Inc | -- |
| ACADIA Pharmaceuticals Inc | -1.043M |
| Cyclacel Pharmaceuticals Inc | -1.049M |